Indexado en

Licencia y uso

Citaciones

Cited 12 times in

Cited 8 times in

Cited 3 times in

Cited 9 times in

Altmetrics

Grant support

This study was funded by the following grants: Fondecyt 1181853, Fondef-IDeA ID15I10080; Fondef-IDeA ID15I20080, Fondef-IDeA ID18I10243, and REDES 180028, from ANID, Chile; and by Project RTI2018-097414-B-I00 from the Spanish Ministry of Science. Doctoral training of JM was supported by ANID-PFCHA/National Doctoral Scholarship 2018/No 21181538.

Análisis de autorías institucional

Compartir

Isolation of HLA-DR-naturally presented peptides identifies T-cell epitopes for rheumatoid arthritis

Publicado en:Annals Of The Rheumatic Diseases. 81 (8): 1096-1105 - 2022-08-01 81(8), DOI: 10.1136/annrheumdis-2021-220371

Autores: Maggi, J; Soto, L; Aravena, O; Catalan, D; Aguillón, JC; Carrascal, M; Abian, J; Neira, O; Cuéllar, MC; James, EA; Jaraquemada, D

Afiliaciones

Resumen

Rheumatoid arthritis (RA) immunopathogenesis revolves around the presentation of poorly characterised self-peptides by human leucocyte antigen (HLA)-class II molecules on the surface of antigen-presenting cells to autoreactive CD4 +T cells. Here, we analysed the HLA-DR-associated peptidome of synovial tissue (ST) and of dendritic cells (DCs) pulsed with synovial fluid (SF) or ST, to identify potential T-cell epitopes for RA.HLA-DR/peptide complexes were isolated from RA ST samples (n=3) and monocyte-derived DCs, generated from healthy donors carrying RA-associated shared epitope positive HLA-DR molecules and pulsed with RA SF (n=7) or ST (n=2). Peptide sequencing was performed by high-resolution mass spectrometry. The immunostimulatory capacity of selected peptides was evaluated on peripheral blood mononuclear cells from patients with RA (n=29) and healthy subjects (n=12) by flow cytometry.We identified between 103 and 888 HLA-DR-naturally presented peptides per sample. We selected 37 native and six citrullinated (cit)-peptides for stimulation assays. Six of these peptides increased the expression of CD40L on CD4 +T cells patients with RA, and specifically triggered IFN-γ expression on RA CD4 +T cells compared with healthy subjects. Finally, the frequency of IFN-γ-producing CD4 +T cells specific for a myeloperoxidase-derived peptide showed a positive correlation with disease activity.We significantly expanded the peptide repertoire presented by HLA-DR molecules in a physiologically relevant context, identifying six new epitopes recognised by CD4 +T cells from patients with RA. This information is important for a better understanding of the disease immunopathology, as well as for designing tolerising antigen-specific immunotherapies.© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Palabras clave